Rowland Carmichael Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
Rowland Carmichael Advisors's MDT Position: Q4 2020 in Review
Rowland Carmichael Advisors reduced its Medtronic (MDT) stake by 0.83% in Q4 2020, selling an estimated $10.2K and leaving 11,147 shares worth $1.31M. The position accounts for 0.41% of the portfolio, ranked #50.
Rowland Carmichael Advisors first reported a position in MDT in Q1 2016 and has held it in 20 quarters since. 1,957 funds tracked by Wall St. Rank hold MDT as of Q4 2020.
- Rowland Carmichael Advisors held 11,147 shares of Medtronic worth $1.31M as of Q4 2020.
- Rowland Carmichael Advisors sold 93 Medtronic shares in Q4 2020, an estimated $10.2K.
- Medtronic made up 0.41% of Rowland Carmichael Advisors's portfolio in Q4 2020, its #50 holding.
- Rowland Carmichael Advisors first reported a position in Medtronic in Q1 2016 and has held it in 20 quarters since.
- 1,957 funds tracked by Wall St. Rank held Medtronic as of Q4 2020.
Based on Rowland Carmichael Advisors's 13F filing for Q4 2020, filed 15 Jan 2021.